← Leaderboards
Luisa Mestroni
University Of Colorado Denver
$6,229,262
Attributed
$15,650,546
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,650,546 · 6
By mechanism
R01$15,645,656 · 4
M01$4,890 · 2
Top collaborators
- Matthew R Taylor9 shared
- Frank I Marcus5 shared
- Jeffrey E Saffitz5 shared
- Jeffrey A Towbin5 shared
- Wojciech Zareba5 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Matthew R Taylor$5,502,265
- Brian L Stauffer$5,871,842
- Mark L Dell'acqua$24,552,179
- Michael R. Bristow$7,111,960
- Kathryn C. Chatfield$1,499,821
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeCardiomyopathiesGene MutationGeneticGenesArrhythmiaCellsCardiacMutationPathway InteractionsLifeSignal PathwayVariantGenotypeHeart FailureRegistriesPreventionProteinsLinkArrhythmogenic Right Ventricular DysplasiaGenomicsMorbidity - Disease RateCardiac MyocytesClinical Phenotype
Grant awards (20)
Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic Targets$679,139
R01 · FY2025 · HL · contact PI
Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic Targets$22,495
R01 · FY2025 · HL · contact PI
Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic Targets$675,327
R01 · FY2024 · HL · contact PI
Engineering Cardiac spheroids to study Laminopathies$37,732
R01 · FY2024 · HL · contact PI
Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic Targets$727,280
R01 · FY2023 · HL · contact PI
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy$508,747
R01 · FY2023 · HL · contact PI
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy$510,302
R01 · FY2022 · HL · contact PI
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy$509,525
R01 · FY2021 · HL · contact PI
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy$524,177
R01 · FY2020 · HL · contact PI
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$2,356,223
R01 · FY2016 · HL
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$2,350,202
R01 · FY2015 · HL
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$2,212,258
R01 · FY2014 · HL
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$79,695
R01 · FY2014 · HL
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$2,156,524
R01 · FY2013 · HL
THE FAMILIAL CARDIOMYOPATHY REGISTRY$514
M01 · FY2008 · RR · contact PI
THE FAMILIAL CARDIOMYOPATHY REGISTRY$4,376
M01 · FY2007 · RR · contact PI
Molecular Epidemiology of Dilated Cardiomyopath$555,058
R01 · FY2005 · HL
Molecular Epidemiology of Dilated Cardiomyopath$566,350
R01 · FY2004 · HL
Molecular Epidemiology of Dilated Cardiomyopath$579,669
R01 · FY2003 · HL
Molecular Epidemiology of Dilated Cardiomyopath$594,953
R01 · FY2002 · HL